Abstract
The blood–brain barrier (BBB) is the major barrier for brain drug delivery and limits the treatment options for central nervous system diseases. To circumvent the BBB, we introduced the focused ultrasound-mediated intranasal brain drug delivery (FUSIN) technique. FUSIN utilizes the nasal route for direct nose-to-brain drug administration, bypassing the BBB and minimizing systemic exposure. It also uses the transcranial application of ultrasound energy focused at a targeted brain region to induce microbubble cavitation, which enhances the transport of intranasally administered agents at the FUS-targeted brain location. FUSIN is unique in that it can achieve noninvasive and localized brain drug delivery with minimized systemic toxicity. The goal of this chapter is to provide a detailed protocol for FUSIN delivery to the mouse brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pardridge WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1):3–14
Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64(7):614–628
Savale S, Mahajan H (2017) Nose to brain: a versatile mode of drug delivery system. Asian J Biomater Res 3(16):16–38
Hadaczek P et al (2006) The ‘perivascular pump’ driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol Ther 14(1):69–78
Nonaka N, Farr SA, Kageyama H, Shioda S, Banks WA (2008) Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins. J Pharmacol Exp Ther 325(2):513–519
Kumral A et al (2017) Intranasal surfactant protein D as neuroprotective rescue in a neonatal rat model of periventricular leukomalacia. J Matern Neonatal Med 30(4):446–451
Rassu G et al (2017) Nose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy. Colloid Surf B Biointerfaces 152:296–301
Zhuang X et al (2015) Grapefruit-derived nanovectors delivering therapeutic miR17 through an intranasal route inhibit brain tumor progression. Mol Ther 24(1):96–105
Benedict C et al (2004) Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29(10):1326–1334
Benedict C et al (2007) Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 32(1):239–243
Krishan M, Gudelsky GA, Desai PB, Genter MB (2014) Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain. Drug Deliv 21(1):8–16
Zhao Y-Z et al (2016) Intranasal delivery of bFGF with nanoliposomes enhances in vivo neuroprotection and neural injury recovery in a rodent stroke model. J Control Release 224:165–175
Bernocchi B, Carpentier R, Lantier I, Ducournau C, Dimier-Poisson I, Betbeder D (2016) Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles. J Control Release 232:42–50
Muntimadugu E, Dhommati R, Jain A, Challa VGS, Shaheen M, Khan W (2016) Intranasal delivery of nanoparticle encapsulated tarenflurbil: apotential brain targeting strategy for Alzheimer’s disease. Eur J Pharm Sci 92:224–234
Illum L (2004) Is nose-to-brain transport of drugs in man a reality. J Pharm Pharmacol 56(1):3–17
Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379(1):146–157
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220(3):640–646
Choi JJ, Selert K, Vlachos F, Wong A, Konofagou EE (2011) Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles. Proc Natl Acad Sci U S A 108(40):16539–16544
Liu H-L et al (2010) Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 107(34):15205–15210
Sun T et al (2017) Closed-loop control of targeted ultrasound drug delivery across the blood–brain/tumor barriers in a rat glioma model. Proc Natl Acad Sci 114(48):E10281–E10290
Downs ME, Buch A, Karakatsani ME, Konofagou EE, Ferrera VP (2015) Blood-brain barrier opening in behaving non-human primates via focused ultrasound with systemically administered microbubbles. Sci Rep 5(October):15076
Kamimura HAS, Flament J, Valette J, Cafarelli A, Badin RA, Larrat B (2019) Passive cavitation detection-based feedback control for ultrasound-mediated blood-brain barrier opening in non-human primates. J Cereb Blood Flow Metab 39(7):1191–1203
Karakatsani MEM, Samiotaki GM, Downs ME, Ferrera VP, Konofagou EE (2017) Targeting effects on the volume of the focused ultrasound-induced blood-brain barrier opening in nonhuman primates in vivo. IEEE Trans Ultrason Ferroelectr Freq Control 64(5):798–810
Marquet F et al (2014) Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates. PLoS One 9(2):e84310
Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N (2012) Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 7(9):e45783
Lipsman N et al (2018) Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound. Nat Commun 9(1):2336
Mainprize T et al (2019) Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study. Sci Rep 9(1):321
Abrahao A et al (2019) First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound. Nat Commun 10(1):4373
Upadhyay A, Dalvi SV (2019) Microbubble formulations: synthesis, stability, modeling and biomedical applications. Ultrasound Med Biol 45(2):301–343
Ferrara K, Pollard R, Borden M (2007) Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9:415–447
Sboros V (2008) Response of contrast agents to ultrasound. Adv Drug Deliv Rev 60(10):1117–1136
Chen H, Kreider W, Brayman AA, Bailey MR, Matula TJ (2011) Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 106(3):034301
Chen H, Brayman AA, Bailey MR, Matula TJ (2010) Blood vessel rupture by cavitation. Urol Res 38(4):321–326
Chen H, Yang GZX, Getachew H, Acosta C, Sierra Sánchez C, Konofagou EE (2016) Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Sci Rep 6(February):28599
Chen H, Chen CC, Acosta C, Wu S-Y, Sun T, Konofagou EE (2014) A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery. PLoS One 9(10):e108880
Ye D et al (2018) Focused ultrasound-enabled delivery of radiolabeled nanoclusters to the pons. J Control Release 283:143–150
Ji R et al (2019) Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson’s disease mouse model. Sci Rep 9:19402
Feshitan JA, Chen CC, Kwan JJ, Borden MA (2009) Microbubble size isolation by differential centrifugation. J Colloid Interface Sci 329(2):316–324
Wang S, Samiotaki G, Olumolade O, Feshitan JA, Konofagou EE (2014) Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier opening. Ultrasound Med Biol 40(1):130–137
Franklin KBJ, Paxinos G (2007) The mouse brain in stereotaxic coordinates. Academic, San Diego
McDannold N, Vykhodtseva N, Hynynen K (2008) Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med Biol 34(6):930–937
McDannold N, Vykhodtseva N, Hynynen K (2008) Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 34(5):834–840
Choi JJ, Pernot M, Small SA, Konofagou EE (2007) Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med Biol 33(1):95–104
Acknowledgments
This work was in part supported by the National Institutes of Health (NIH) grant R01MH116981 and R01EB027223.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Ye, D., Chen, H. (2022). Focused Ultrasound-Mediated Intranasal Brain Drug Delivery Technique (FUSIN). In: Rasooly, A., Baker, H., Ossandon, M.R. (eds) Biomedical Engineering Technologies. Methods in Molecular Biology, vol 2394. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1811-0_26
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1811-0_26
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1810-3
Online ISBN: 978-1-0716-1811-0
eBook Packages: Springer Protocols